SciVision Biotech Inc
TWSE:1786

Watchlist Manager
SciVision Biotech Inc Logo
SciVision Biotech Inc
TWSE:1786
Watchlist
Price: 82.3 TWD 3.39% Market Closed
Market Cap: NT$6.2B

Operating Margin

22.5%
Current
Declining
by 4.6%
vs 3-y average of 27.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22.5%
=
Operating Income
NT$200m
/
Revenue
NT$890.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22.5%
=
Operating Income
NT$200m
/
Revenue
NT$890.4m

Peer Comparison

Country Company Market Cap Operating
Margin
TW
SciVision Biotech Inc
TWSE:1786
5.9B TWD
Loading...
JP
Hoya Corp
TSE:7741
8.7T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.7B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.8B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
120.3B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
11.9B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
KR
HLB Inc
KOSDAQ:028300
8.8T KRW
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF
Loading...

Market Distribution

Higher than 90% of companies in Taiwan
Percentile
90th
Based on 1 045 companies
90th percentile
22.5%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

SciVision Biotech Inc
Glance View

Market Cap
6.2B TWD
Industry
Health Care

SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.

Intrinsic Value
88.39 TWD
Undervaluation 7%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
22.5%
=
Operating Income
NT$200m
/
Revenue
NT$890.4m
What is SciVision Biotech Inc's current Operating Margin?

The current Operating Margin for SciVision Biotech Inc is 22.5%, which is below its 3-year median of 27.1%.

How has Operating Margin changed over time?

Over the last 3 years, SciVision Biotech Inc’s Operating Margin has decreased from 22.9% to 22.5%. During this period, it reached a low of 22.5% on Oct 30, 2025 and a high of 30% on Sep 30, 2024.

Back to Top